Literature DB >> 23709228

Cerebellar contribution to anger recognition deficits in Huntington's disease.

Wilfried Scharmüller1, Rottraut Ille, Anne Schienle.   

Abstract

Although there is increasing evidence that cerebellar loss of grey matter volume (GMV) is associated with affective deficits, this has not been tested for patients suffering from Huntington's disease (HD), who show a pronounced impairment in the recognition of anger. We assessed GMV in 18 symptomatic HD patients and 18 healthy controls using voxel-based morphometry. The GMV of cerebellar subregions was correlated with participants' intensity and accuracy ratings for facial expressions of basic emotions from the Karolinska Directed Emotional Faces (Lundqvist et al. 1998). The patients gave lower and less accurate anger ratings for angry faces than controls. This anger recognition deficit was correlated with atrophy of selected hemispheric and vermal regions of the cerebellum. Furthermore, cerebellar volume reductions of the HD patients were associated with longer disease duration and greater functional impairment. The data imply that anger recognition deficits could potentially serve as indicators of disease onset and progression in HD. Furthermore, the patients might profit from specific affect trainings.

Entities:  

Mesh:

Year:  2013        PMID: 23709228      PMCID: PMC4495283          DOI: 10.1007/s12311-013-0492-9

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  19 in total

1.  Functional topography of primary emotion processing in the human cerebellum.

Authors:  Oliver Baumann; Jason B Mattingley
Journal:  Neuroimage       Date:  2012-03-23       Impact factor: 6.556

2.  The relation between anger and different forms of disgust: implications for emotion recognition impairments in Huntington's disease.

Authors:  Andrew J Calder; Jill Keane; Andrew W Young; Andrew D Lawrence; Sarah Mason; Roger A Barker
Journal:  Neuropsychologia       Date:  2010-05-16       Impact factor: 3.139

Review 3.  An emerging concept. The cerebellar contribution to higher function.

Authors:  J D Schmahmann
Journal:  Arch Neurol       Date:  1991-11

4.  Emotional activation of limbic circuitry in elderly normal subjects in a PET study.

Authors:  S Paradiso; R G Robinson; N C Andreasen; J E Downhill; R J Davidson; P T Kirchner; G L Watkins; L L Ponto; R D Hichwa
Journal:  Am J Psychiatry       Date:  1997-03       Impact factor: 18.112

5.  Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat.

Authors:  H H Ruocco; I Lopes-Cendes; L M Li; M Santos-Silva; F Cendes
Journal:  Braz J Med Biol Res       Date:  2006-08       Impact factor: 2.590

6.  Emotion recognition and experience in Huntington disease: a voxel-based morphometry study.

Authors:  Rottraut Ille; Axel Schäfer; Wilfried Scharmüller; Christian Enzinger; Helmuth Schöggl; Hans-Peter Kapfhammer; Anne Schienle
Journal:  J Psychiatry Neurosci       Date:  2011-11       Impact factor: 6.186

7.  Impaired recognition and experience of disgust following brain injury.

Authors:  A J Calder; J Keane; F Manes; N Antoun; A W Young
Journal:  Nat Neurosci       Date:  2000-11       Impact factor: 24.884

8.  Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis.

Authors:  H D Rosas; W J Koroshetz; Y I Chen; C Skeuse; M Vangel; M E Cudkowicz; K Caplan; K Marek; L J Seidman; N Makris; B G Jenkins; J M Goldstein
Journal:  Neurology       Date:  2003-05-27       Impact factor: 9.910

9.  Unified Huntington's Disease Rating Scale: reliability and consistency. Huntington Study Group.

Authors: 
Journal:  Mov Disord       Date:  1996-03       Impact factor: 10.338

10.  Emotion recognition and experience in Huntington's disease: is there a differential impairment?

Authors:  Rottraut Ille; Anna Katharina Holl; Hans-Peter Kapfhammer; Karin Reisinger; Axel Schäfer; Anne Schienle
Journal:  Psychiatry Res       Date:  2011-05-07       Impact factor: 3.222

View more
  6 in total

1.  Characterization of Cerebellar Atrophy and Resting State Functional Connectivity Patterns in Sporadic Adult-Onset Ataxia of Unknown Etiology (SAOA).

Authors:  Xueyan Jiang; J Faber; I Giordano; J Machts; Ch Kindler; A Dudesek; O Speck; Ch Kamm; E Düzel; F Jessen; A Spottke; St Vielhaber; H Boecker; T Klockgether; L Scheef
Journal:  Cerebellum       Date:  2019-10       Impact factor: 3.847

2.  Consensus paper: radiological biomarkers of cerebellar diseases.

Authors:  Leonardo Baldarçara; Stuart Currie; M Hadjivassiliou; Nigel Hoggard; Allison Jack; Andrea P Jackowski; Mario Mascalchi; Cecilia Parazzini; Kathrin Reetz; Andrea Righini; Jörg B Schulz; Alessandra Vella; Sara Jane Webb; Christophe Habas
Journal:  Cerebellum       Date:  2015-04       Impact factor: 3.847

3.  Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease.

Authors:  Robert Christian Wolf; Philipp Arthur Thomann; Fabio Sambataro; Nadine Donata Wolf; Nenad Vasic; G Bernhard Landwehrmeyer; Sigurd Dietrich Süßmuth; Michael Orth
Journal:  J Neurol       Date:  2015-01-28       Impact factor: 4.849

4.  Cerebellar Grey Matter Volumes in Reactive Aggression and Impulsivity in Healthy Volunteers.

Authors:  Elze M L Wolfs; Jana Klaus; Dennis J L G Schutter
Journal:  Cerebellum       Date:  2022-03-05       Impact factor: 3.847

5.  The role of the amygdala during emotional processing in Huntington's disease: from pre-manifest to late stage disease.

Authors:  Sarah L Mason; Jiaxiang Zhang; Faye Begeti; Natalie Valle Guzman; Alpar S Lazar; James B Rowe; Roger A Barker; Adam Hampshire
Journal:  Neuropsychologia       Date:  2015-02-17       Impact factor: 3.139

6.  Tracking the Cognitive, Social, and Neuroanatomical Profile in Early Neurodegeneration: Type III Cockayne Syndrome.

Authors:  Sandra Baez; Blas Couto; Eduar Herrera; Yamile Bocanegra; Natalia Trujillo-Orrego; Lucia Madrigal-Zapata; Juan Felipe Cardona; Facundo Manes; Agustin Ibanez; Andres Villegas
Journal:  Front Aging Neurosci       Date:  2013-11-26       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.